Sesija 9: Savremeni pristup psihofarmakologiji: od novih mehanizama delovanja do personalizovane terapije

Drage koleginice i kolege,

Da li ste spremni za putovanje od fundamentalnih istraživanja do svakodnevne kliničke prakse? Nastavljamo sa predstavljanjem naučnog programa 9. Kongresa farmaceuta Srbije sa međunarodnim učešćem, a ovog puta zavirujemo u oblast koja se trenutno nalazi u periodu intenzivnog preoblikovanja. Predstavljamo vam Sesiju 9.

Savremeni pristup psihofarmakologiji: od novih mehanizama delovanja do personalizovane terapije

Predavanja u okviru ove sesije donose potpuno nove uvide i posvećena su savremenim pristupima u razvoju i primeni lekova u psihijatriji. Očekuje vas diskusija o novim mehanizmima delovanja sagledanim sa farmakološkog i kliničkog stanovišta, kao i o mestu biljnih lekovitih proizvoda u lečenju psihijatrijskih poremećaja. Pored toga, posebna pažnja biće posvećena optimizaciji terapije escitalopramom kroz primenu farmakogenetskih, farmakokinetičkih i psihometrijskih biomarkera. Zajedno ćemo potražiti odgovor na ključno pitanje: kako personalizovani pristup zaista može unaprediti efikasnost i bezbednost farmakoterapije psihijatrijskih oboljenja?

Detaljnije informacije o predavanjima, predavačima i satnici sesije možete pogledati ispod!

Dear colleagues,

Are you ready for a journey from fundamental research to everyday clinical practice? We are continuing the presentation of the scientific program of the 9th Serbian Congress of Pharmacy with International Participation, and this time we are diving into a field currently undergoing a period of intense transformation. Introducing Session 9.

Contemporary approaches in psychopharmacology: from novel mechanisms of action to personalized therapy

The lectures in this session bring fresh insights, focusing on contemporary approaches to the development and clinical use of psychiatric medications. Expect a discussion on novel mechanisms of action examined through both pharmacological and clinical perspectives, as well as the role of herbal medicinal products in psychiatric disorders. Additionally, special attention will be given to optimizing escitalopram therapy using pharmacogenetic, pharmacokinetic, and psychometric biomarkers. Together, we aim to answer a crucial question: how exactly can a personalized approach improve the efficacy and safety of pharmacotherapy in psychiatric diseases?

Detailed information about the lectures, speakers, and session schedule can be found below!